#zepbound

Lilly Gains Lead in Obesity Drug Race: Novo Nordisk Setback Analysis

Uncover why Lilly's Zepbound is surging ahead in the obesity drug battle! Our analysis reveals Novo Nordisk's setback & what it means for the future of wei...